Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
Evaluation of 3D Ultrasound Vaginal Manometry for Estimating the Optimal Pessary Size for Patients With Pelvic Organ Prolapse
1 other identifier
interventional
24
1 country
1
Brief Summary
Symptoms of female pelvic floor dysfunction, such as incontinence and pelvic organ prolapse, can be alleviated by using pessaries, which are passive medical devices that are inserted in the vagina to support the pelvic organs. Currently, pessaries are fit through trial and error after manual examination, the accuracy of which depends on the physician's expertise level. The objective of this study is to evaluate the feasibility of using 3D translabial ultrasound imaging of the vagina at various distension volumes to predict the pessary size for successful fit. Ultrasound images will be obtained using commercially available 3D ultrasound probes (Philips, Netherlands), as well as a commercially available 2D ultrasound probe (Philips, Netherlands), which is linearly scanned to capture a 3D volume. The linear scanning will be performed by attaching the 2D probe to a motorized hand-held scanner, which is used to tilt and move the probe to acquire images. Please note that the hand-held scanner does not come in contact with the patient. To distend the vagina, a sterile bag is inserted in the vagina and gradually filled with water using a commercially available urodynamic system (Laborie, Canada) until the vaginal capacity is reached, without causing any discomfort to the patient. This image acquisition technique, previously reported in the literature, is referred to as 3D ultrasound vaginal manometry in this study. To achieve the objective of this project, 35 pelvic organ prolapse patients, who (i) are current pessary users, (ii) can perform self-care of the pessary, and (iii) can provide informed consent, will be invited to participate in the study. Patients will be asked to remove their pessary prior to ultrasound imaging. Then, 3D ultrasound vaginal manometry will be performed, using the technique described above. Ultrasound images will be analyzed once data acquisition is completed. The size of the pessary estimated from ultrasound images will be compared with the actual pessary size used by the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2019
CompletedFirst Posted
Study publicly available on registry
September 23, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedApril 30, 2024
April 1, 2024
3.6 years
May 1, 2019
April 26, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
FEASIBILITY: The predicted pessary size
The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient
Up to 3 months following data collection
FEASIBILITY: The predicted pessary shape
The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.
Up to 3 months following data collection
Study Arms (1)
Patients with Pelvic Organ Prolapse
OTHERPatients who meet the inclusion criteria will be recruited. Ultrasound images of the pelvic floor and vaginal cavity will be analyzed to predict pessary size and type. This will be compared against the pessary size and type being used already by the patient.
Interventions
3D ultrasound of the pelvic floor and vaginal cavity will be obtained by using a commercial ultrasound system.
Eligibility Criteria
You may qualify if:
- Current pessary users (\> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
- Are able to provide informed consent
- Can perform self-care, i.e. removing and inserting the pessary themselves
- Are willing to remove their pessary 2 days before the ultrasound examination date.
You may not qualify if:
- Inability to give informed consent
- Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
- History of pelvic radiation or surgery, (including hysterectomy)
- Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
- Inability to perform the Valsalva maneuver or pelvic floor contraction
- Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
- Lack of sensation at the pelvic floor.
- Being pregnant at the time of the examination.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Western University, Canadalead
- Cosm Medical Corp.collaborator
Study Sites (1)
Victoria Hospital
London, Ontario, N6A 5W9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2019
First Posted
September 23, 2019
Study Start
February 1, 2020
Primary Completion
September 5, 2023
Study Completion
November 1, 2023
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Data will be de-identified, and only the aggregate results will be used for publication. Patient information will not be made public or shared with researchers outside of the study team.